S&P 500 7,356.16 â–ŧ 9.30 (-0.13%) DOW 51,833.81 ▲ 166.97 (+0.32%) NASDAQ 25,470.02 â–ŧ 117.02 (-0.46%) US Markets Closed â€ĸ 12:04 AM ET

HYEX

Healthy Extracts Inc.

Price Chart
Latest Quote

$2.15

-0.55 (-20.37%)
Current Price
Previous Close $2.70
Open $2.15
Day High $2.15
Day Low $2.15
Volume 930
Fetched: 2026-06-25T04:04:31
Stock Information
Shares Outstanding 14.73M
Total Debt $2.56M
Cash Equivalents $164K
Revenue $5.19M
Net Income $-683K
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $31.67M
P/E Ratio 71.67
EPS (TTM) $0.03
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$38.71M
Sales$5.19M
Income$-683K
Book/sh$1.42
Cash/sh$0.01
Employees22
Financial Ratios
Quick Ratio0.26
Current Ratio0.69
Debt/Eq10.66
Returns & Margins
ROA-4.89%
ROE-5.68%
Gross Margin57.52%
Operating Margin-20.41%
Profit Margin-13.15%
Ownership
Insider Ownership80.53%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E16.54
P/S6.10
P/B1.51
Analyst Data
Recommendationnone
Technical Indicators
SMA20$2.53
SMA50$1.84
SMA200$1.93
RSI6.80
ATR0.0422
Shares Float3.29M
Volatility-0.79
Rel Volume2.86
Performance History
Week-20.37%
Month+90.27%
Quarter+36.08%
6 Months+12.56%
YTD+41.45%
Year+36.94%
3 Years-66.19%
5 Years-77.03%
10 Years-99.97%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-24 $2.15 930
2026-06-23 $2.70 0
2026-06-22 $2.70 116
2026-06-18 $2.70 0
2026-06-17 $2.70 0
2026-06-16 $2.70 0
2026-06-15 $2.70 0
2026-06-12 $2.70 0
2026-06-11 $2.70 0
2026-06-10 $2.70 0
2026-06-09 $2.70 300
2026-06-08 $2.66 0
2026-06-05 $2.66 0
2026-06-04 $2.66 0
2026-06-03 $2.66 0
2026-06-02 $2.66 578
2026-06-01 $2.60 1,185
2026-05-29 $2.25 1,000
2026-05-28 $1.93 1,500
2026-05-27 $1.32 900
2026-05-26 $1.13 0
About Healthy Extracts Inc.

Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.

Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $1,201,959 $864,055 $879,951 $981,520
Cost Of Revenue $1,201,959 $864,055 $879,951 $981,520
Total Revenue $3,113,279 $2,485,866 $2,251,469 $1,676,598
Operating Revenue $3,113,279 $2,485,866 $2,251,469 $1,676,598
Expenses
Total Expenses $3,296,428 $4,729,709 $3,163,058 $3,565,776
Other Income Expense $-471,270 $-52,140 $-6,841 $-45,492
Net Non Operating Interest Income Expense $-186,252 $-176,948 $-64,690 $-52,453
Total Other Finance Cost $186,252 $176,948 $64,690 $52,453
Operating Expense $2,094,469 $3,865,654 $2,283,107 $2,584,256
Selling And Marketing Expense $697,533 - - -
General And Administrative Expense $1,396,936 $3,865,654 $2,283,107 $2,584,256
Interest Expense - - - $52,453
Interest Expense Non Operating - - - $52,453
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-840,671 $-2,472,931 $-983,121 $-1,987,122
Net Interest Income $-186,252 $-176,948 $-64,690 $-52,453
Normalized Income $-369,401 $-2,420,791 $-976,280 $-1,941,630
Net Income From Continuing And Discontinued Operation $-840,671 $-2,472,931 $-983,121 $-1,987,122
Net Income Common Stockholders $-840,671 $-2,472,931 $-983,121 $-1,987,122
Net Income $-840,671 $-2,472,931 $-983,121 $-1,987,122
Net Income Including Noncontrolling Interests $-840,671 $-2,472,931 $-983,121 $-1,987,122
Net Income Continuous Operations $-840,671 $-2,472,931 $-983,121 $-1,987,122
Pretax Income $-840,671 $-2,472,931 $-983,121 $-1,987,122
Operating Income $-183,149 $-2,243,844 $-911,590 $-1,889,178
Gross Profit $1,911,320 $1,621,810 $1,371,517 $695,078
Special Income Charges - $0 $2,643 $39,833
Per Share
Diluted EPS $-0.28 $-0.85 $-0.34 $-1.20
Basic EPS $-0.28 $-0.85 $-0.34 $-1.20
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $288,121 $-2,189,509 $-903,871 $-1,838,586
Total Unusual Items $-471,270 $-52,140 $-6,841 $-45,492
Total Unusual Items Excluding Goodwill $-471,270 $-52,140 $-6,841 $-45,492
Reconciled Depreciation $-139 $2,195 $878 $5,100
EBITDA (Bullshit earnings) $-183,149 $-2,241,649 $-910,712 $-1,884,078
EBIT $-183,149 $-2,243,844 $-911,590 $-1,889,178
Diluted Average Shares $2,978,540 $2,915,410 $2,854,290 $2,660,082
Basic Average Shares $2,978,540 $2,915,410 $2,854,290 $2,660,082
Diluted NI Availto Com Stockholders $-840,671 $-2,472,931 $-983,121 $-1,987,122
Gain On Sale Of Security $-471,270 $-52,140 $-9,484 $-85,325
Selling General And Administration $2,094,469 $3,865,654 $2,283,107 $2,584,256
Other Gand A $963,878 $2,172,909 $2,283,107 $2,584,256
Salaries And Wages $433,058 $1,692,745 - -
Gain On Sale Of Ppe - $0 $2,643 $0
Write Off - $0 $0 -
Other Special Charges - - - $-39,833
Impairment Of Capital Assets - - - $0
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-304,764 $239,448 $1,163,188 $1,755,597
Total Assets $2,377,973 $2,635,014 $2,781,118 $3,029,579
Total Non Current Assets $718,586 $735,336 $737,531 $716,175
Non Current Prepaid Assets $0 $16,890 $16,890 $0
Goodwill And Other Intangible Assets $715,141 $715,141 $715,141 $715,141
Other Intangible Assets $521,881 $521,881 $521,881 $521,881
Current Assets $1,659,387 $1,899,678 $2,043,587 $2,313,404
Other Current Assets $8,984 $71,583 $-1 -
Current Deferred Assets $149,274 $151,931 $0 -
Prepaid Assets $16,890 $0 $53,015 -
Inventory $1,361,216 $1,626,283 $1,819,128 $1,957,966
Receivables $11,003 $30,440 $105,794 $133,340
Accounts Receivable $11,003 $30,440 $105,794 $133,340
Cash Cash Equivalents And Short Term Investments $112,020 $19,441 $65,651 $222,098
Cash And Cash Equivalents $112,020 $19,441 $65,651 $222,098
Cash Financial $112,020 $19,441 $65,651 $222,098
Other Non Current Assets - $-1 $-1 $-1
Debt
Net Debt $820,655 $1,033,619 $527,869 $120,518
Total Debt $941,897 $1,127,511 $593,520 $342,616
Current Debt And Capital Lease Obligation $941,897 $1,127,511 $593,520 $342,616
Current Debt $932,675 $1,053,060 $593,520 $342,616
Other Current Borrowings $531,526 $609,467 $318,150 $171,750
Liabilities
Total Liabilities Net Minority Interest $1,967,596 $1,680,425 $902,789 $558,841
Total Non Current Liabilities Net Minority Interest $0 $1 $1 $0
Current Liabilities $1,967,596 $1,680,424 $902,788 $558,841
Other Current Liabilities $625,420 $154,151 $102,011 $92,526
Current Notes Payable $2,427 $361,093 $275,370 $170,866
Payables And Accrued Expenses $400,279 $398,762 $207,257 $123,699
Interest Payable $99,422 $66,851 $21,387 $27,168
Payables $52,248 $116,842 $91,316 $37,267
Accounts Payable $52,248 $116,842 $91,316 $37,267
Equity
Common Stock Equity $410,377 $954,589 $1,878,329 $2,470,738
Total Equity Gross Minority Interest $410,377 $954,589 $1,878,329 $2,470,738
Stockholders Equity $410,377 $954,589 $1,878,329 $2,470,738
Retained Earnings $-19,240,344 $-18,399,673 $-15,926,742 $-14,943,620
Other
Treasury Shares Number $4,166 - - -
Ordinary Shares Number $2,989,406 $2,954,104 $2,876,437 $2,819,868
Share Issued $2,993,572 $2,954,104 $2,876,437 $2,819,868
Tangible Book Value $-304,764 $239,448 $1,163,188 $1,755,597
Invested Capital $1,343,052 $2,007,649 $2,471,849 $2,813,354
Working Capital $-308,209 $219,254 $1,140,799 $1,754,563
Capital Lease Obligations $9,222 $74,451 $0 -
Total Capitalization $410,377 $954,589 $1,878,329 $2,470,738
Treasury Stock $5,400 $0 - -
Additional Paid In Capital $19,301,589 $18,999,770 $17,459,899 $17,075,974
Capital Stock $354,532 $354,492 $345,172 $338,384
Common Stock $354,532 $354,492 $345,172 $338,384
Preferred Stock $0 $0 $0 $0
Current Capital Lease Obligation $9,222 $74,451 $0 -
Line Of Credit $398,722 $82,500 - -
Current Accrued Expenses $348,031 $281,920 $115,941 $86,432
Goodwill $193,260 $193,260 $193,260 $193,260
Net PPE $3,445 $3,306 $5,501 $1,035
Gross PPE $3,445 $3,306 $5,501 $46,979
Other Properties $3,445 $3,306 $5,501 -
Inventories Adjustments Allowances $-781,759 $-1,611,257 - $-1,914,891
Other Inventories $-300 - - $3,872,857
Finished Goods $186,938 $225,567 $310,600 $194,490
Work In Process $23,954 $13,290 $24,764 $5,668
Raw Materials $1,932,383 $2,998,683 $1,483,764 $1,757,808
Accumulated Depreciation - - $-44,709 $-45,944
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $281,968 $-415,749 $-398,608 $-997,302
Operating Activities
Operating Cash Flow $281,968 $-415,749 $-390,621 $-901,298
Cash Flow From Continuing Operating Activities $281,970 $-415,750 $-390,621 $-901,298
Operating Gains Losses $773,128 $1,691,331 $411,584 $694,161
Investing Activities
Investing Cash Flow $0 $0 $-5,344 $-96,004
Cash Flow From Continuing Investing Activities - $0 $-5,344 $-96,004
Capital Expenditure - - $-7,987 $-96,004
Net Other Investing Changes - - $2,643 -
Financing Activities
Repurchase Of Capital Stock $-5,400 $-90,000 $-11,386 -
Financing Cash Flow $-189,389 $369,539 $239,518 $1,160,199
Cash Flow From Continuing Financing Activities $-189,389 $369,539 $239,519 $1,160,199
Net Common Stock Issuance $-5,400 $-90,000 $-11,386 $995,199
Net Other Financing Charges - $68,888 $-1 -
Issuance Of Capital Stock - - - $995,199
Common Stock Issuance - - - $995,199
Other
Repayment Of Debt $-592,789 $-793,095 $-488,095 $0
Issuance Of Debt $408,800 $1,183,746 $739,000 $165,000
End Cash Position $112,020 $19,441 $65,651 $222,098
Beginning Cash Position $19,441 $65,651 $222,098 $59,201
Changes In Cash $92,579 $-46,210 $-156,447 $162,897
Common Stock Payments $-5,400 $-90,000 $-11,386 -
Net Issuance Payments Of Debt $-183,989 $390,651 $250,905 $165,000
Net Short Term Debt Issuance $408,800 $820,783 $275,370 $0
Short Term Debt Issuance $408,800 $820,783 $275,370 $0
Net Long Term Debt Issuance $-592,789 $-430,132 $-24,465 $165,000
Long Term Debt Payments $-592,789 $-793,095 $-488,095 $0
Long Term Debt Issuance $0 $362,963 $463,630 $165,000
Change In Working Capital $313,104 $363,655 $180,038 $386,563
Change In Other Working Capital $2,657 $-98,916 $-53,015 -
Change In Other Current Liabilities $-65,229 $74,451 $0 -
Change In Other Current Assets $62,599 $-71,583 $0 -
Change In Payables And Accrued Expense $28,573 $191,505 $83,558 $46,912
Change In Accrued Expense $93,168 $165,979 $29,510 $74,481
Change In Interest Payable $59,628 $45,464 $-5,781 $24,271
Change In Payable $-64,595 $25,526 $54,048 $-27,569
Change In Account Payable $-64,595 $25,526 $54,048 $-27,569
Change In Inventory $265,067 $192,845 $138,838 $459,717
Change In Receivables $19,437 $75,353 $27,547 $-120,066
Changes In Account Receivables $19,437 $75,353 $27,547 $-120,066
Other Non Cash Items $36,546 $1 $-1 -
Depreciation Amortization Depletion $-139 $2,195 $878 $5,100
Depreciation And Amortization $-139 $2,195 $878 $5,100
Gain Loss On Investment Securities $773,128 $1,691,331 $411,584 $694,161
Net Income From Continuing Operations $-840,671 $-2,472,931 $-983,121 $-1,987,122
Net PPE Purchase And Sale - $0 $-7,987 $0
Purchase Of PPE - $0 $-7,987 $0
Change In Prepaid Assets - $0 $-16,890 $0
Net Business Purchase And Sale - - $0 $0
Sale Of Business - - $0 $0
Net Intangibles Purchase And Sale - - $0 $-96,004
Stock Based Compensation - - $0 $0
Asset Impairment Charge - - $0 $0
Short Term Debt Payments - - - $0
Purchase Of Business - - - $0
Fetched: 2026-02-02